Date Filed | Type | Description |
10/05/2023 |
4
| Thompson Travis Alvin (Chief Accounting Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 54 shares
@ $20, valued at
$1.1k
|
|
10/05/2023 |
4
| Keen Nicholas (Chief Scientific Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 272 shares
@ $20, valued at
$5.4k
|
|
10/05/2023 |
4
| Crockett Nigel (Chief Business Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 442 shares
@ $20, valued at
$8.8k
|
|
10/05/2023 |
4
| Milnes Alistair (COO) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 442 shares
@ $20, valued at
$8.8k
|
|
10/05/2023 |
4
| Lee Kevin (CEO) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 1,470 shares
@ $20, valued at
$29.4k
|
|
10/05/2023 |
4
| Skynner Michael (Chief Technology Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 442 shares
@ $20, valued at
$8.8k
|
|
10/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
10/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
10/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
10/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
10/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
10/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/03/2023 |
8-K
| Quarterly results |
07/19/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/19/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
07/13/2023 |
8-K
| Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Other Events, Financial Statements...
Docs:
|
"Bicycle Therapeutics plc 4,705,884 American Depositary Shares representing 4,705,884 Ordinary Shares, nominal value £0.01 per share 4,705,882 Non-Voting Ordinary Shares, nominal value £0.01 per share",
"Description of the Non-Voting Ordinary Shares",
"Granta Park, Great Abington" |
|
07/13/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
07/12/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
07/06/2023 |
4
| Thompson Travis Alvin (Chief Accounting Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 61 shares
@ $25.1, valued at
$1.5k
|
|
07/06/2023 |
4
| Skynner Michael (Chief Technology Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 451 shares
@ $25.1, valued at
$11.3k
|
|
07/06/2023 |
4
| Milnes Alistair (COO) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 451 shares
@ $25.1, valued at
$11.3k
|
|
07/06/2023 |
4
| Lee Kevin (CEO) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 1,498 shares
@ $25.1, valued at
$37.6k
|
|
07/06/2023 |
4
| Keen Nicholas (Chief Scientific Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 336 shares
@ $25.1, valued at
$8.4k
|
|
07/06/2023 |
4
| Crockett Nigel (Chief Business Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 451 shares
@ $25.1, valued at
$11.3k
|
|
07/03/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/26/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
|